Chronic subcutaneous administration of the cardiac peptide BNP in experimental heart failure does not result in the development of tolerance to exogenous BNP
Horng H. Chen, John A. Schirger, Alessandro Catalliotti, Gail Harty, John C. Burnett Jr.Volume:
41
Year:
2003
Language:
english
DOI:
10.1016/s0735-1097(03)81923-x
File:
PDF, 148 KB
english, 2003